Poor Sleep May Complicate Young Diabetics' Blood Sugar Control

Key points
- Poor sleep may be undermining the efforts of children with type 1 diabetes when it comes to controlling their blood sugar, new research indicates.
- In the study, researchers tracked sleep patterns among 50 kids with type 1 diabetes aged 10 to 16.
- In addition, experiencing this form of sleep deficit was linked to poorer performance in school as well as higher blood sugar levels, according to the report published in the January issue of the journal Sleep.
- "Despite adhering to recommendations for good diabetic health, many youth with type 1 diabetes have difficulty maintaining control of their blood sugars," the study's principal investigator, Michelle Perfect, of the University of Arizona in Tucson, said in a news release from the American Academy of Sleep Medicine.
Poor sleep may be undermining the efforts of children with type 1 diabetes when it comes to controlling their blood sugar, new research indicates.
In the study, researchers tracked sleep patterns among 50 kids with type 1 diabetes aged 10 to 16. Compared with similarly aged kids, the children with diabetes were found to be spending more time in a lighter stage of sleep.
In addition, experiencing this form of sleep deficit was linked to poorer performance in school as well as higher blood sugar levels, according to the report published in the January issue of the journal Sleep.
"Despite adhering to recommendations for good diabetic health, many youth with type 1 diabetes have difficulty maintaining control of their blood sugars," the study's principal investigator, Michelle Perfect, of the University of Arizona in Tucson, said in a news release from the American Academy of Sleep Medicine.
"We found that it could be due to abnormalities in sleep, such as daytime sleepiness, lighter sleep and sleep apnea. All of these make it more difficult to have good blood sugar control," Perfect added.
The study authors also found that about one-third of the children with type 1 diabetes had sleep apnea, irrespective of their weight. What's more, those who had sleep apnea also had much higher blood sugar levels. Sleep apnea is a disorder that causes frequent pauses in breathing during sleep, which leads to daytime sleepiness and fatigue.
The investigators noted that sleep apnea is a condition that has previously been associated with type 2 diabetes (which typically affects adults). The findings among these study participants may mean that it is also an issue among younger diabetes patients, they said in the news release.
In the meantime, Perfect pointed out that "sleep problems were associated with lower grades, poorer performance on state standardized tests, poor quality of life and abnormalities in daytime behavior. On the upside, sleep is a potentially modifiable health behavior, so these kids could be helped by a qualified professional to get a better night's sleep."
###
HealthDay News
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Diabetes & Hormones →
NewsDiabetics who use meters to monitor their glucose have better control over disease
Researchers from the Icahn School of Medicine at Mount Sinai will present several new studies at ENDO 2013, The Endocrine Society's Annual Meeting & Expo (ENDO) from June 15-18 in San Francisco. Mount Sinai researchers…
17 June 2013
NewsTreatment of sleep apnea improves glucose levels in prediabetes
Optimal treatment of sleep apnea in patients with prediabetes improves blood sugar (glucose) levels and thus can reduce cardiometabolic risk, according to a study to be presented at the ATS 2013 International Conference…
20 May 2013
NewsDrug achieves 6% weight loss in diabetics
Novo Nordisk in Denmark said a clinical trial found the drug liraglutide achieved 6 percent weight loss in overweight or obese people with type 2 diabetes. This was the second phase 3a trial to be completed as part of…




